When neurons are out of shape, antidepressants may not work

IMAGE: These are human serotonergic neuron projections (red) and cell bodies (green). view more  Credit: Salk Institute LA JOLLA–(March 22, 2019) Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed medication for major depressive disorder (MDD), yet scientists still do not understand why the treatment does not work in nearly thirty percent of patients with…

Details

UTSW researchers identify new mechanism to reduce inflammation

IMAGE: Dr. Zixu Liu view more  Credit: UT Southwestern DALLAS – March 21, 2019 – UT Southwestern researchers have identified two proteins that act as gatekeepers to dampen a potentially life-threatening immune response to chronic infection. The proteins – the transcription factors SIX1 and SIX2 – activate cellular pathways required for fetal development and later switch…

Details

Sleep problems, Alzheimer’s disease are linked, but which comes first?

Rockville, Md. (March 22, 2019)–A new article explores the pathophysiological factors that link sleep disturbances and Alzheimer’s disease. Better understanding of this connection may lead to potential diagnostics and therapeutics for Alzheimer’s disease and other neurodegenerative diseases and dementia. The article is published ahead of print in the Journal of Neurophysiology (JNP). Alzheimer’s research has…

Details

Genetesis CardioFlux™ platform receives FDA 510(k) clearance

IMAGE: Patient, monitored by nurse, in a Genetesis Cardioflux™ scanner. view more  (Mason, OH March 22, 2019 8 am) Genetesis, a medical technology company focused on using biomagnetic imaging to enable rapid, noninvasive and accurate chest pain triage, has received FDA 510(k) clearance for its cardiac imaging platform. The platform pairs the CardioFlux™ Magnetocardiograph with the…

Details